Articoli
https://www.pharmadoc.it/wp-content/uploads/2019/01/Accordo-quadro-garesito.jpg
1280
1920
rossana
https://www.pharmadoc.it/wp-content/uploads/2020/12/pharmadoc-logo.png
rossana2019-01-10 12:04:092019-05-23 15:08:53Gare per biosimilari prevale l’utilizzo dell’accordo quadro. Il caso delle epoetine.
https://www.pharmadoc.it/wp-content/uploads/2018/09/Sede-Consip-Roma.jpg
3312
4416
rossana
https://www.pharmadoc.it/wp-content/uploads/2020/12/pharmadoc-logo.png
rossana2018-09-28 17:36:082019-05-23 14:49:52Epoetina alfa, beta e zeta di nuovo in un lotto unico